Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"
Manager TitleAgeSince
Chief Executive Officer - -
Director TitleAgeSince
Director/Board Member 57 01/03/2011
Director/Board Member - -
Director/Board Member 58 -
Change 5-day change 1-year change 3-year change Capi.($)
-50.00%-75.00% - - 0
+4.56%+13.31%+103.22%+104.30% 4.28B
+4.47%-0.40%+68.88%+112.48% 2.81B
+3.92%+3.83%-25.50%-42.30% 2.01B
-0.51%-4.17%+97.47%-52.78% 1.75B
+11.50%+13.97%+37.50%+217.72% 1.35B
-3.47%-0.89%-17.63%+19.83% 837M
-0.38%+4.42%+152.43%-60.21% 767M
-10.32%-23.08%+54.29% - 596M
-1.73%-5.87%-30.76%-15.90% 508M
Average -4.20%-0.83%+48.88%+35.39% 1.66B
Weighted average by Cap. +2.98%+2.78%+61.95%+58.80%
Logo MediBIc Group
MediBIC Group is a Japan-based company comprised of four business segments. The Biomarker Drug Discovery Supports segment provides support solution services for new drug development, including the provision of analytical, clinical trial coordinate, data analytical and pharmacogenomics (PGx) test support services, as well as the sale of development support products and system architecture business. The Tailor-made Healthcare Management Supports segment provides private deoxypentose nucleic acid (DNA) bank services and other health support services. The Drug Discovery segment adds value to candidate compounds of genomic, advanced and general new drugs to acquire part of intellectual properties. The Investment and Incubation segment is engaged in the management and operation of funds, and the trading of securities.
Employees
-
  1. Stock Market
  2. Stocks
  3. 2369 Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!